These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19765374)

  • 1. [A promising new class of antituberculous molecules].
    Saint-Joanis B; Brosch R
    Med Sci (Paris); 2009; 25(8-9):663-5. PubMed ID: 19765374
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethambutol sensitivity test.
    Vadász I; Fodor T; Mester J
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):603; author reply 603-4. PubMed ID: 12797706
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment with new antitubercular agents].
    Gartmann J
    Dtsch Med Wochenschr; 1968 Nov; 93(47):2281-2. PubMed ID: 4301079
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitubercular potential of plants: a brief account of some important molecules.
    Negi AS; Kumar JK; Luqman S; Saikia D; Khanuja SP
    Med Res Rev; 2010 Jul; 30(4):603-45. PubMed ID: 19626592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of antituberculous agents and ultrastructure of mycobacteria.
    Oka S; Yamaguchi J; Ariji F; Madokoro K; Kumano N
    Sci Rep Res Inst Tohoku Univ Med; 1971 Jul; 18(1):7-13. PubMed ID: 5005200
    [No Abstract]   [Full Text] [Related]  

  • 6. Rationale for chemotherapy of tuberculosis and current recommendations.
    Kumar L
    Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuberculosis peritonitis.
    DiMase JD; Agrawal D
    Med Health R I; 2007 Nov; 90(11):363-4. PubMed ID: 18092489
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C; Andreis G
    G Ital Chemioter; 1966; 13(1):109-27. PubMed ID: 4967318
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental study on the antituberculous activity of ofloxacins].
    Duan L; Liang G; Li H
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Apr; 20(2):98-100. PubMed ID: 10072834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis in Acukland.
    Swinburn PD
    N Z Med J; 1973 Dec; 78(505):520-5. PubMed ID: 4205888
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
    Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Jul; 41(28):507-9. PubMed ID: 1630427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mycobacterium tuberculosis after five 5-year periods of specific therapy. Biological aspects].
    Daddi G
    Ann Ist Carlo Forlanini; 1969; 29(4):283-5. PubMed ID: 5004327
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antituberculous activities of the tuberactinomycins in vitro and in experimental animals].
    Koseki Y; Okamoto S; Muroashi T
    Kekkaku; 1973 May; 48(5):189-96. PubMed ID: 4200134
    [No Abstract]   [Full Text] [Related]  

  • 15. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 16. [Resistance to antitubercular drugs in patients with tuberculosis registered in the antituberculosis clinics in Poland 1966-1980].
    Szczuka I
    Pneumonol Pol; 1982 Oct; 50(10):497-501. PubMed ID: 6820494
    [No Abstract]   [Full Text] [Related]  

  • 17. [New antitubercular drugs and their clinical use].
    Pregowski W
    Pol Tyg Lek; 1971 Feb; 26(7):244-7. PubMed ID: 4994370
    [No Abstract]   [Full Text] [Related]  

  • 18. [Incidence of tuberculostatic-resistant Mycobacterium tuberculosis. Clinical aspects and impact on therapy and clinical course].
    Esteban J; Gegúndez MI; García-Corbeira P; Soriano F
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):415-9. PubMed ID: 8260512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ethambutol in phthisiological experimentation and practice].
    Galassi A; Campanini A; Ciaccia A
    G Ital Chemioter; 1966; 13(1):90-108. PubMed ID: 4967907
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative data from an experimental-clinical study of new antituberculosis drugs].
    Utkin VV
    Antibiotiki; 1972 Sep; 17(9):851-6. PubMed ID: 4631726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.